![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Professor Donald F. Weaver, University of Toronto 
Wednesday 02 March 2016, 14:15-15:15
An In Silico High Throughput Screening Strategy to Identify Putative Disease Modifying Agents for Chronic Neurological Disorders
- 👤 Speaker: Professor Donald F. Weaver, University of Toronto 🔗 Website
- 📅 Date & Time: Wednesday 02 March 2016, 14:15 - 15:15
- 📍 Venue: Department of Chemistry, Cambridge, Unilever lecture theatre
Questions? Contact
Lisa Masters
Abstract
Neurology is sometimes referred to as the “diagnose and adios” specialty, referring to the dearth of “curative” disease modifying drugs (DMDs) for the majority of major neurological disorders. Epilepsy and dementia are two of the most common neurological disorders. Although “symptomatic” agents are available, there are no DMDs for either of these disorders. In an attempt to identify agents, we created two in silico libraries for high throughput screening: the first (11.8 million entries) consists of commercially available organic molecules; the second consists of all molecules (MW
Series This talk is part of the Theory - Chemistry Research Interest Group series.
Included in Lists
- All Talks (aka the CURE list)
- Department of Chemistry
- Department of Chemistry, Cambridge, Unilever lecture theatre
- Featured lists
- Lennard-Jones Centre external
- School of Physical Sciences
Note: Ex-directory lists are not shown.